(Q37868373)

English

Bleeding risk assessment and management in atrial fibrillation patients: a position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on Thrombosis

scientific article published on May 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

24 August 2017

Bleeding risk assessment and management in atrial fibrillation patients: a position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on Thrombosis (English)

1 reference

Europe PubMed Central

24 August 2017

atrial fibrillation

0 references

0 references

0 references

5

object named as

Elaine Hylek

1 reference

Europe PubMed Central

24 August 2017

Paulus Kirchhof

object named as

Paulus Kirchhof

11

0 references

1

object named as

Gregory Y H Lip

1 reference

Europe PubMed Central

24 August 2017

Gualtiero Palareti

10

object named as

Gualtiero Palareti

1 reference

Europe PubMed Central

24 August 2017

7

object named as

Deirdre A Lane

1 reference

Europe PubMed Central

24 August 2017

Laurent Fauchier

3

object named as

Laurent Fauchier

1 reference

Europe PubMed Central

24 August 2017

Francisco Marín

9

object named as

Francisco Marin

1 reference

Europe PubMed Central

24 August 2017

8

object named as

Marcel Levi

1 reference

Europe PubMed Central

24 August 2017

14

object named as

Andrea Rubboli

1 reference

Europe PubMed Central

24 August 2017

Felicita Andreotti

2

object named as

Felicita Andreotti

1 reference

Europe PubMed Central

24 August 2017

15

object named as

Daniela Poli

1 reference

Europe PubMed Central

24 August 2017

Jean-Philippe Collet

13

object named as

Jean-Philippe Collet

1 reference

Europe PubMed Central

24 August 2017

Document Reviewers

12

object named as

Document reviewers:

1 reference

Europe PubMed Central

24 August 2017

author name string

Kurt Huber

4

1 reference

Europe PubMed Central

24 August 2017

Eve Knight

6

1 reference

Europe PubMed Central

24 August 2017

John Camm

16

1 reference

Europe PubMed Central

24 August 2017

publication date

1 May 2011

1 reference

Europe PubMed Central

24 August 2017

1 reference

Europe PubMed Central

24 August 2017

13

1 reference

Europe PubMed Central

24 August 2017

723-746

1 reference

Europe PubMed Central

24 August 2017

5

1 reference

Europe PubMed Central

24 August 2017

Outcome parameters for trials in atrial fibrillation: executive summary

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Warfarin discontinuation after starting warfarin for atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

New oral anticoagulant drugs in cardiovascular disease.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Treatments for stroke prevention in atrial fibrillation: a network meta-analysis and indirect comparisons versus dabigatran etexilate.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Effect of age on stroke prevention therapy in patients with atrial fibrillation: the atrial fibrillation investigators

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Validation of Clinical Classification Schemes for Predicting Stroke

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Prevention and treatment of major blood loss

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Stroke severity in atrial fibrillation. The Framingham Study

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

The increasing incidence of anticoagulant-associated intracerebral hemorrhage.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

A national survey of the management of atrial fibrillation with antithrombotic drugs in Italian primary care.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Dabigatran and warfarin in vitamin K antagonist-naive and -experienced cohorts with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Dabigatran versus warfarin in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Major haemorrhagic complications during oral anticoagulant therapy in a Danish population-based cohort.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Risk factors for complications of chronic anticoagulation. A multicenter study. Warfarin Optimized Outpatient Follow-up Study Group

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Bleeding risk during oral anticoagulation in atrial fibrillation patients older than 80 years

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Warfarin for atrial fibrillation in community-based practise

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Safety of treatment with oral anticoagulants in the elderly. A systematic review

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Stroke patients with atrial fibrillation have a worse prognosis than patients without: data from the Austrian Stroke registry

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Variation in the definitions of bleeding in clinical trials of patients with acute coronary syndromes and undergoing percutaneous coronary interventions and its impact on the apparent safety of antithrombotic drugs

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Ticagrelor versus clopidogrel in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

The outpatient bleeding risk index: validation of a tool for predicting bleeding rates in patients treated for deep venous thrombosis and pulmonary embolism

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Bleeding Risk Index in an anticoagulation clinic. Assessment by indication and implications for care

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF).

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Clinical end points in coronary stent trials: a case for standardized definitions

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Risk factors for anticoagulation-related bleeding complications in patients with atrial fibrillation: a systematic review

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Adverse impact of bleeding on prognosis in patients with acute coronary syndromes.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions: appropriateness of including bleeding as a component of a quadruple end point

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Incidence and predictors of bleeding after contemporary thrombolytic therapy for myocardial infarction. The Global Utilization of Streptokinase and Tissue Plasminogen activator for Occluded coronary arteries (GUSTO) I Investigators

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE).

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Predictors and 1-year outcome of major bleeding in patients with non-ST-elevation acute coronary syndromes: insights from the Canadian Acute Coronary Syndrome Registries

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Hemorrhagic and ischemic strokes compared: stroke severity, mortality, and risk factors

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

The Acute STroke Registry and Analysis of Lausanne (ASTRAL): design and baseline analysis of an ischemic stroke registry including acute multimodal imaging.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Incidence and predictors of drug-eluting stent thrombosis during and after discontinuation of thienopyridine treatment

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Optimizing long-term dual aspirin/clopidogrel therapy in acute coronary syndromes: when does the risk outweigh the benefit?

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Should anticoagulation be resumed after intracerebral hemorrhage?

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Trial of different intensities of anticoagulation in patients with prosthetic heart valves.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

The optimal intensity of vitamin K antagonists in patients with mechanical heart valves: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Risk factors for intracranial hemorrhage in outpatients taking warfarin

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Optimal oral anticoagulant therapy in patients with mechanical heart valves.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Comparison of outcomes among patients randomized to warfarin therapy according to anticoagulant control: results from SPORTIF III and V.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Effect of study setting on anticoagulation control: a systematic review and metaregression

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Effect of home testing of international normalized ratio on clinical events

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Management strategies for optimal control of anticoagulation in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

A C1173T dimorphism in the VKORC1 gene determines coumarin sensitivity and bleeding risk

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

The impact of genetic polymorphisms and patient characteristics on warfarin dose requirements: a cross-sectional study in Iran

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Increased risk of intracranial hemorrhage when aspirin is combined with warfarin: A meta-analysis and hypothesis

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Warfarin plus aspirin after myocardial infarction or the acute coronary syndrome: meta-analysis with estimates of risk and benefit

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case-control study

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Upper gastrointestinal bleeding among users of NSAIDs: a population-based cohort study in Denmark

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Risk of upper gastrointestinal hemorrhage in warfarin users treated with nonselective NSAIDs or COX-2 inhibitors

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Choosing antithrombotic therapy for elderly patients with atrial fibrillation who are at risk for falls

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Patients' perspectives on taking warfarin: qualitative study in family practice

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Cost-effectiveness of warfarin and aspirin for prophylaxis of stroke in patients with nonvalvular atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Cost-effectiveness of preference-based antithrombotic therapy for patients with nonvalvular atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Implementing evidence based medicine in general practice: audit and qualitative study of antithrombotic treatment for atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

The impact of patients' preferences on the treatment of atrial fibrillation: observational study of patient based decision analysis

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Decision analysis and guidelines for anticoagulant therapy to prevent stroke in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Impact of a patient decision aid on care among patients with nonvalvular atrial fibrillation: a cluster randomized trial

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

A patient decision aid to support shared decision-making on anti-thrombotic treatment of patients with atrial fibrillation: randomised controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Universities and tobacco money

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Avoidance hierarchies and preferences for anticoagulation--semi-qualitative analysis of older patients' views about stroke prevention and the use of warfarin

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

The effect of qualitative vs. quantitative presentation of probability estimates on patient decision-making: a randomized trial

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Influence of decision aids on patient preferences for anticoagulant therapy: a randomized trial

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Values and preferences in oral anticoagulation in patients with atrial fibrillation, physicians' and patients' perspectives: protocol for a two-phase study

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

An international survey of physician and patient understanding, perception, and attitudes to atrial fibrillation and its contribution to cardiovascular disease morbidity and mortality

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Uninterrupted warfarin for periprocedural anticoagulation in catheter ablation of typical atrial flutter: a safe and cost-effective strategy.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Periprocedural stroke and management of major bleeding complications in patients undergoing catheter ablation of atrial fibrillation: the impact of periprocedural therapeutic international normalized ratio.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Consensus document on antithrombotic therapy in the setting of electrophysiological procedures

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Radiofrequency ablation of atrial fibrillation under therapeutic international normalized ratio: a safe and efficacious periprocedural anticoagulation strategy

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Atrial fibrillation ablation in patients with therapeutic international normalized ratios

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Long-term results of catheter ablation in paroxysmal atrial fibrillation: lessons from a 5-year follow-up

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Parenteral anticoagulants: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

The relationship between warfarin, aspirin, and clopidogrel continuation in the peri-procedural period and the incidence of hematoma formation after device implantation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Pacemaker and implantable cardioverter defibrillator implantation without reversal of warfarin therapy

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Pocket hematoma after pacemaker or implantable cardioverter defibrillator surgery: influence of patient morbidity, operation strategy, and perioperative antiplatelet/anticoagulation therapy.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Postoperative low-molecular-weight heparin bridging is associated with an increase in wound hematoma following surgery for pacemakers and implantable defibrillators

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Perioperative anticoagulation in patients having implantation of a cardiac pacemaker or defibrillator: a systematic review and practical management guide.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Preparation for pacemaker or implantable cardiac defibrillator implants in patients with high risk of thrombo-embolic events: oral anticoagulation or bridging with intravenous heparin? A prospective randomized trial

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Is antiarrhythmia device implantation safe under dual antiplatelet therapy?

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Guidelines for cardiac pacing and cardiac resynchronization therapy. The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Radial versus femoral approach for percutaneous coronary diagnostic and interventional procedures; Systematic overview and meta-analysis of randomized trials.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Radial versus femoral access for coronary angiography or intervention and the impact on major bleeding and ischemic events: a systematic review and meta-analysis of randomized trials

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Long-term outcomes in patients undergoing coronary stenting on dual oral antiplatelet treatment requiring oral anticoagulant therapy.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Aspirin and clopidogrel with or without phenprocoumon after drug eluting coronary stent placement in patients on chronic oral anticoagulation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Time and cardiac risk of surgery after bare-metal stent percutaneous coronary intervention.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Cardiac risk of noncardiac surgery after percutaneous coronary intervention with drug-eluting stents

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Antiplatelet therapy and coronary stents in perioperative medicine--the two sides of the coin

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Gui

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Perioperative use of antithrombotic agents: recommendations of the American College of Chest Physicians (ACCP) and the French Superior Health Authority (HAS)

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET/OFFSET study.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

To continue or discontinue aspirin in the perioperative period: a randomized, controlled clinical trial

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Urgent surgery in patients with a recently implanted coronary drug-eluting stent: a phase II study of 'bridging' antiplatelet therapy with tirofiban during temporary withdrawal of clopidogrel

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

How safely and for how long can warfarin therapy be withheld in prosthetic heart valve patients hospitalized with a major hemorrhage?

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Prognostic implications of warfarin cessation after major trauma: a population-based cohort analysis

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Treatment of coumarin-associated coagulopathy: a systematic review and proposed treatment algorithms.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Effects of patient age and physician training on choice and dose of benzodiazepine hypnotic drugs

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Comparison of oral vs intravenous phytonadione (vitamin K1) in patients with excessive anticoagulation: a prospective randomized controlled study

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Treatment of warfarin-associated intracerebral hemorrhage: literature review and expert opinion.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Prothrombin complex concentrate (Beriplex P/N) for emergency anticoagulation reversal: a prospective multinational clinical trial

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Disseminated intravascular coagulation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Safety of factor VIII inhibitor bypass activity (FEIBA): 10-year compilation of thrombotic adverse events

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Percutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation: results from the international multi-center feasibility trials.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Left atrial appendage closure with Amplatzer cardiac plug in atrial fibrillation: initial European experience.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Management of Antithrombotic Therapy in Atrial Fibrillation Patients Presenting with Acute Coronary Syndrome and/or Undergoing Percutaneous Coronary Intervention/ Stenting

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Development of a Contemporary Bleeding Risk Model for Elderly Warfarin Recipients

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR126

21 January 2018

Identifiers

10.1093/EUROPACE/EUR126

1 reference

Europe PubMed Central

24 August 2017

1 reference

Europe PubMed Central

24 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37868373&oldid=1865507993"